Immunohistochemical study of decorin expression in polyps and carcinomas of the colon

Medical Science Monitor

Volumn 14, Issue 10, 2008, Pages

  Augoff, Katarzyna ^a   Rabczynski, Jerzy ^a   Tabola, Renata ^a   Czapla, Leszek ^a   Ratajczak, Katarzyna ^a   Grabowski, Krzysztof ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Colon cancer; Colonic polyps; Decorin; SLRP

Indexed keywords

DECORIN;

ARTICLE; COLON ADENOCARCINOMA; COLON ADENOMA; COLON CARCINOMA; COLON MUCOSA; COLON POLYP; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PROTEIN EXPRESSION; RECTUM POLYP; STROMA;

ADULT; AGED; AGED, 80 AND OVER; COLON; COLONIC POLYPS; COLORECTAL NEOPLASMS; EXTRACELLULAR MATRIX PROTEINS; HUMANS; HYPERPLASIA; INTESTINAL MUCOSA; MIDDLE AGED; PROTEOGLYCANS; YOUNG ADULT;

EID: 54249114166     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Bond JH: Polyp guideline: diagnosis, treatment and surveillance for patients with colorectal polyps. Am J Gastroenterol, 2000; 95(11): 3053-63
2. Preston SL, Wong WM, Chan AOO et al: Bottom-up histogenesis of colorectal adenomas: origin in the monocryptal adenoma and initial expansion by crypt fission. Cancer Res, 2003; 63: 3819-25
3. Jass JR, Iino H, Ruszkiewicz A et al: Neoplastic progression occurs through mutator pathways in hyperplastic polyposis of the colorectum. Gut, 2000; 47: 43-49
4. Jass JR, Baker K, Zlobec I et al: Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a "fusion" pathway to colorectal cancer. Histopathol, 2006; 49: 121-31
5. Shinya H, Wolff WI: Morphology, anatomic distribution and cancer potential of colonic polyps. Ann Sur, 1979; 6(190): 679-83
6. Church JM: Clinical significance of small colorectal polyps. Dis Colon Rectum, 2004; 47: 481-85
7. Adams JC, Watt FM: Regulation of development and differentiation by the extracellular matrix. Development, 1993; 117: 1183-98
8. Ariztia EV, Lee CJ, Gogoi R, Fishman DA: The tumor microenvironment: key to early detection. Crit Rev Clin Lab Sci, 2006; 43(5-6): 393-425
9. Desoize B: Stromal reaction and tumor growth. Crit Rev Oncol/Hematol, 2004; 49: 173-76
10. Kresse H, Schönherr E: Proteoglycans of the extracellular matrix and growth control. J Cell Physiol, 2001; 189: 266-74
11. Adany R, Heimer R, Caterson B et al: Altered expression of chondroitin sulfate proteoglycan in the stroma of human colon carcinoma. Hypomethlation of PG-40 gene correlates with increased PG-40 content and mRNA levels. J Biol Chem, 1990; 265(19): 11389-96
12. Wgrowski Y, Maquart FX: Involvement of stromal proteoglycans in tumor progression. Crit Rev Oncol Hematol, 2004; 49: 259-68
13. Iozzo RV: Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem, 1998; 67: 609-52
14. Reed C, Iozzo RV: The role of decorin in collagen fibrillogenesis and skin homeostasis. Glycoconjugate J, 2003; 19: 249-55
15. Ständer M, Naumann U, Wick W, Weller M: Transforming growth factor-β and p21: multiple molecular targets of decorin-mediated suppression of neoplastic growth. Cell Tissue Res, 1999; 296: 221-27
16. Tufvesson E, Westergren-Thorsson G: Tumor necrosis factor-α interacts with bigycan and decorin. FEBS Let, 2002; 530: 124-28
17. Moscatello DK, Santra M, Mann DM et al: Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor. J Clin Ivest, 1998; 101: 406-12
18. De Luca A, Santra M, Baldi A et al: Decorin-induced growth supression is associated with up-regulation of p21, an inhibitor of cyclin-dependent kinases. J Biol Chem, 1996; 271(31): 18961-65
19. Waf1. Blood, 2001; 98: 2124-33
20. Boman BM, Walters R, Fields JZ et al: Colonic crypt changes during adenoma development in familial adenomatous polyposis. Am J Pathol, 2004; 165(5): 1489-98
21. Colucci P, Yale S, Rall C: Colorectal polyps. Clin Med Res, 2003; 1(3): 261
22. Arifler D, Pavlova I, Gillenwater A et al: Light scattering from collagen fiber networks: micro-optical properties of normal and neoplastic stroma. Biophys J, 2007; 92(9): 3260-74
23. Grant DS, Yenisey C, Rose RW et al: Decorin suppresses tumor cell-mediated angiogenesis. Oncogene, 2002; 21: 4765-77
24. Hunzelman N, Schönherr E, Bonnekoh B et al: Altered immunohistochemical expression of small proteoglycans in the tumor tissue and stroma of basal cell carcinoma. J Invest Dermatol, 1995;104: 509-23
25. Lu YP, Ishiwata T, Kawahara K et al: Expression of lumican in human colorectal cancer cells. Pathol International, 2002; 52: 519-26
26. Skandalis SS, Theocharis AD, Theocharis DA et al: Matrix proteoglycans are markedly affected in advanced laryngeal sqamous cell carcinoma. Biochim Biophys Acta, 2004; 1689: 152-61
27. Troup S, Njue C, Kliewer EV et al: Reduced expression of the small leucine-rich proteoglycans, lumican and decorin is associated with poor outcome in node-negative invasive breast cancer. Clin Cancer Res, 2003; 9: 207-14
28. Santra M, Skorski T, Calabretta B et al: De novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells. Proc Natl Acad Sci USA, 1995; 92: 7016-20